BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$140M |
| 2 |
iShares US Financials ETF
IYF
|
+$119M |
| 3 |
AGN
Allergan plc
AGN
|
+$100M |
| 4 |
Charter Communications
CHTR
|
+$95.1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$82.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$909M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.73% |
| 2 | Financials | 5.47% |
| 3 | Healthcare | 4.96% |
| 4 | Consumer Discretionary | 4.64% |
| 5 | Industrials | 3.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EBSB
2776
DELISTED
Meridian Bancorp, Inc.
EBSB
| $228K | ﹤0.01% |
11,373
+3,735
| +49% | +$73.2K |
|
2777
Sonic Automotive
SAH
$2.51B
| $228K | ﹤0.01% |
7,358
+1,733
| +31% | +$54.8K |
|
2778
iShares US Medical Devices ETF
IHI
$3.48B
| $228K | ﹤0.01% |
5,166
+4,800
| +1,311% | +$202K |
|
2779
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.75B
| $227K | ﹤0.01% |
4,753
+1,828
| +62% | +$85.6K |
|
2780
RadNet
RDNT
$6.08B
| $227K | ﹤0.01% |
11,194
+4,683
| +72% | +$80.3K |
|
2781
BCE
BCE
$21.7B
| $227K | ﹤0.01% |
4,900
| – | – |
|
2782
Genesco
GCO
$394M
| $226K | ﹤0.01% |
4,716
-78
| -2% | -$3.24K |
|
2783
Hamilton Lane
HLNE
$5.91B
| $226K | ﹤0.01% |
3,791
-31
| -0.8% | -$1.79K |
|
2784
John B. Sanfilippo & Son
JBSS
$1.01B
| $226K | ﹤0.01% |
2,472
+1,106
| +81% | +$107K |
|
|
HSII
2785
DELISTED
Heidrick & Struggles
HSII
| $225K | ﹤0.01% |
6,933
+3,958
| +133% | +$117K |
|
2786
Artivion
AORT
$1.39B
| $225K | ﹤0.01% |
8,296
+2,601
| +46% | +$63.9K |
|
2787
ATN International
ATNI
$491M
| $225K | ﹤0.01% |
4,056
+2,120
| +110% | +$121K |
|
|
MNK
2788
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $224K | ﹤0.01% |
64,213
+24,907
| +63% | +$77.7K |
|
2789
Floor & Decor
FND
$6.27B
| $224K | ﹤0.01% |
4,408
+1,397
| +46% | +$65.5K |
|
2790
Vicor
VICR
$10.4B
| $223K | ﹤0.01% |
4,777
+1,811
| +61% | +$69K |
|
2791
Innovative Industrial Properties
IIPR
$1.67B
| $223K | ﹤0.01% |
2,934
+1,261
| +75% | +$97.8K |
|
2792
Mesa Laboratories
MLAB
$633M
| $222K | ﹤0.01% |
892
+302
| +51% | +$70.7K |
|
|
THR
2793
DELISTED
Thermon Group Holdings
THR
| $222K | ﹤0.01% |
8,284
+2,351
| +40% | +$59.3K |
|
2794
Liberty Latin America Class A
LILA
$1.67B
| $222K | ﹤0.01% |
17,931
+6,791
| +61% | +$78.9K |
|
2795
Tredegar Corp
TG
$278M
| $221K | ﹤0.01% |
9,897
+5,024
| +103% | +$105K |
|
|
PENG
2796
Penguin Solutions Inc
PENG
$3.12B
| $221K | ﹤0.01% |
11,638
+8,082
| +227% | +$125K |
|
2797
Kodiak Sciences
KOD
$2.5B
| $221K | ﹤0.01% |
3,067
-227
| -7% | -$8.26K |
|
2798
Astronics
ATRO
$4.57B
| $220K | ﹤0.01% |
9,450
+1,166
| +14% | +$28.6K |
|
2799
Lakeland Financial Corp
LKFN
$1.56B
| $219K | ﹤0.01% |
4,476
+587
| +15% | +$27.3K |
|
|
SPTN
2800
DELISTED
SpartanNash
SPTN
| $219K | ﹤0.01% |
15,349
+9,652
| +169% | +$127K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2019 Portfolio in Review
As of Q4 2019, BNP Paribas Financial Markets held 4,613 positions worth $54.9B, down 2.5% from $56.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.1B in Q4 2019, closing 185 positions and reducing 1,420 holdings. Its most notable exit was Celgene Corp, an estimated $56.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.3% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares US Financials ETF worth $124M.
- BNP Paribas Financial Markets's largest Q4 2019 buy was iShares US Financials ETF: 1,800,000 shares worth $124M.
- BNP Paribas Financial Markets added most to Bristol-Myers Squibb in Q4 2019, an estimated $140M increase.
- BNP Paribas Financial Markets's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Celgene Corp in Q4 2019, selling an estimated $56.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $54.9B portfolio in Q4 2019.
- BNP Paribas Financial Markets opened 106 new positions and closed 185 in Q4 2019.
- BNP Paribas Financial Markets's portfolio value fell 2.5% quarter-over-quarter to $54.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.